Diabetes Mellitus Clinical Trials
53 studies are recruiting for diabetes mellitus in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
Early Tracking of Childhood Health Determinants (ETCHED) Study
Background: Children s weight has increased sharply in recent years. This may put them at higher risk for health problems. High blood glucose in a pregnant mother and too much weight gain during pregnancy also may have long-term effects on the child s health. Children who become overweight or obese…
- Stage
- Not phased
- Ages
- 0 to 99
- Site
- NIDDK, Phoenix, Phoenix, Arizona
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
-
Genetic Studies of Insulin and Diabetes
The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to …
- Stage
- Not phased
- Ages
- 0 to 120
- Site
- National Institutes of Health Clinical Center, Bethesda, Maryland
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
-
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Helios Clinical Research, Paradise Valley, Arizona
- Locations
- 8 in total
- Run by
- Abbott Diabetes Care
-
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Nationwide Children's Hospital, Columbus, Ohio
- Run by
- Nationwide Children's Hospital
-
Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education), in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 8 prima…
- Stage
- Not phased
- Ages
- 22 and older
- Site
- UW School of Medicine and Public Health, Madison, Wisconsin
- Run by
- University of Wisconsin, Madison
-
Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial
The goal of this clinical trial is to evaluate local and systemic factors involved in palatal mucosal healing after Free Gingival Graft harvest in diabetic patients and to compare them with those in non-diabetic patients. Diabetic and non-diabetic volunteers of both sexes aged ≥ 18 years with gingi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- College of Dentistry - University of Kentucky, Lexington, Kentucky
- Run by
- Mauro Santamaria
-
Impact GLP-1 Agonists Following Bariatric
Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control hunger, induce satiety and plays a role in the metabolic health of a person. GLP-1 receptor agonists (GLP1-RAs) have been show…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- University of Missouri Hospital, Columbia, Missouri
- Run by
- University of Missouri-Columbia
-
SPYRAL GEMINI Pilot Study
The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Stanford Hospital and Clinics, Stanford, California
- Locations
- 18 in total
- Run by
- Medtronic Vascular
-
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for clinicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with ca…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- Hartford HealthCare, Hartford, Connecticut
- Locations
- 3 in total
- Run by
- University of Connecticut
-
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory at Memorial Sloan Kettering to be changed (modified) to become MSLN-targeted CAR T cells, the CAR T-cell therapy that part…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. …
- Stage
- Not phased
- Ages
- 21 to 80
- Site
- First Nations Community Health Source, Albuquerque, New Mexico
- Locations
- 3 in total
- Run by
- University of New Mexico
-
Total Contact Soft Cast in Diabetic Foot Ulcers
To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Minnesota, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the trea…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Univ of Alabama Birmingham, Birmingham, Alabama
- Locations
- 74 in total
- Run by
- Novo Nordisk A/S
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults. The main question it aims to answer is: What combination of four family components in combination with a standard behavioral weight loss program yields optimal w…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- Run by
- University of North Carolina, Chapel Hill
-
Inflammation, Diabetes, Ethnicity and Obesity Cohort
Obesity affects over one third of US adults (>72 million, with BMI ≥30 kg/m2), and the proportion of US adults with BMI ≥40 kg/m2 has doubled in the last 20 years. Obesity is associated with increased mortality through its linkage to comorbidities including diabetes, hypertension, dyslipidemia, ost…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- University of California San Francisco, San Francisco, California
- Run by
- University of California, San Francisco
-
Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
The goal of the Arizona Community Engagement Alliance (AZ-CEAL) will be to combine social care with healthcare programs. The study will be connecting selected patients from clinics with trained community health workers (CHW) who will assist participants in getting the help that is needed for their …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Banner University Medical Center South, Tucson, Arizona
- Locations
- 2 in total
- Run by
- Sairam Parthasarathy
-
Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers
Within their lifetime, over 30% of people living with diabetes will develop a diabetic foot ulcer (DFU), many of which will never heal and may require amputation. Removable cast walkers (RCWs) are commonly prescribed to offload (treat) DFUs. While RCWs are prescribed to be worn during all weight be…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Rosalind Franklin University of Medicine and Science, North Chicago, Illinois
- Run by
- Rosalind Franklin University of Medicine and Science
-
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus
The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic Pancreatitis (CP) or Recurrent Acute Pancreatitis (RAP) or Acute Pancreatitis (AP) associated with Diabetes Mellitus (DM). To evaluate mixed meal re…
- Stage
- Phase 2
- Ages
- 18 to 80
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 3 in total
- Run by
- Mayo Clinic
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Black individuals are more likely to have decreased insulin sensitivity which results in a high risk for the development of cardiometabolic disease. The reasons for this are incompletely understood. Natriuretic peptides (NPs) are hormones produced by the heart that play a role in regulating the met…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- University of Alabama at Birmingham, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
- Stage
- Phase 2
- Ages
- 24 to 65
- Site
- Arizona State University, Phoenix, Arizona
- Run by
- Arizona State University
-
Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycem…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Mayo Clinic
-
Care Transitions App for Patients With Multiple Chronic Conditions
The objective of this study is to widely implement and evaluate the Care Transitions App in a randomized controlled trial. The app the investigators designed for patients with multiple chronic conditions has four envisioned modules: 1) falls-reduction content, 2) a digital post-discharge transition…
- Stage
- Not phased
- Ages
- 55 and older
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Run by
- Brigham and Women's Hospital
-
SPARK-CGM Implementation
Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in prima…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Medical Group (MMG), The Bronx, New York
- Run by
- Montefiore Medical Center
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy w…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Mayo Clinic
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.